Alignment Healthcare (NASDAQ:ALHC) Stock Price Down 7.1% on Analyst Downgrade

Posted by George Bondi on Aug 3rd, 2026

Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Free Report) traded down 7.1% during mid-day trading on Monday after Raymond James Financial downgraded the stock from a strong-buy rating to an outperform rating. Raymond James Financial now has a $19.00 price target on the stock. Alignment Healthcare traded as low as $14.10 and last traded at $13.7980. Approximately 1,150,863 shares changed hands during trading, a decline of 74% from the average session volume of 4,433,767 shares. The stock had previously closed at $14.85.

ALHC has been the topic of a number of other research reports. KeyCorp reaffirmed an “overweight” rating on shares of Alignment Healthcare in a research note on Wednesday, June 10th. Wolfe Research started coverage on Alignment Healthcare in a research note on Friday, April 17th. They issued an “outperform” rating and a $24.00 price target for the company. Zacks Research downgraded Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a report on Monday, July 6th. Weiss Ratings upgraded Alignment Healthcare from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Thursday, May 7th. Finally, UBS Group reiterated a “neutral” rating on shares of Alignment Healthcare in a research report on Wednesday, July 8th. Seven equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $24.00.

View Our Latest Stock Report on Alignment Healthcare

Insider Activity

In other Alignment Healthcare news, CEO John E. Kao sold 298,000 shares of the company’s stock in a transaction that occurred on Friday, July 10th. The shares were sold at an average price of $19.86, for a total value of $5,918,280.00. Following the completion of the transaction, the chief executive officer directly owned 1,088,766 shares in the company, valued at approximately $21,622,892.76. This represents a 21.49% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Hyong Kim sold 35,951 shares of the firm’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $19.86, for a total transaction of $713,986.86. Following the transaction, the insider directly owned 331,750 shares of the company’s stock, valued at $6,588,555. The trade was a 9.78% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 1,039,951 shares of company stock worth $19,976,967. Company insiders own 5.20% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Handelsbanken Fonder AB grew its position in shares of Alignment Healthcare by 85.7% in the 2nd quarter. Handelsbanken Fonder AB now owns 55,700 shares of the company’s stock valued at $1,326,000 after buying an additional 25,700 shares during the last quarter. GAMMA Investing LLC raised its position in shares of Alignment Healthcare by 46.6% during the second quarter. GAMMA Investing LLC now owns 3,368 shares of the company’s stock worth $80,000 after acquiring an additional 1,070 shares during the last quarter. Versant Capital Management Inc lifted its stake in shares of Alignment Healthcare by 463.3% in the second quarter. Versant Capital Management Inc now owns 1,380 shares of the company’s stock worth $33,000 after acquiring an additional 1,135 shares during the period. Bank of America Corp DE lifted its stake in shares of Alignment Healthcare by 156.5% in the first quarter. Bank of America Corp DE now owns 3,215,667 shares of the company’s stock worth $56,660,000 after acquiring an additional 1,961,778 shares during the period. Finally, Edgestream Partners L.P. bought a new stake in Alignment Healthcare in the first quarter valued at approximately $4,852,000. 86.19% of the stock is owned by institutional investors and hedge funds.

Alignment Healthcare Price Performance

The firm has a market capitalization of $2.99 billion, a P/E ratio of 75.66, a PEG ratio of 1.98 and a beta of 1.05. The company has a fifty day moving average of $19.70 and a 200 day moving average of $19.75. The company has a debt-to-equity ratio of 1.22, a current ratio of 1.70 and a quick ratio of 1.70.

Alignment Healthcare (NASDAQ:ALHC – Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.13 by $0.04. Alignment Healthcare had a net margin of 0.89% and a return on equity of 20.02%. The firm had revenue of $1.34 billion during the quarter, compared to analyst estimates of $1.31 billion. During the same quarter last year, the business earned $0.07 EPS. The company’s revenue was up 31.6% compared to the same quarter last year. Sell-side analysts predict that Alignment Healthcare, Inc. will post 0.2 earnings per share for the current year.

Alignment Healthcare Company Profile

(Get Free Report)

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.

Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.